CD8A and breast cancer: In summary, we have identified an association of SIRT2 with enhanced CD8+ TEM cell differentiation in breast cancer, an event mediated at least in part by activated aerobic oxidation as well as the inhibition of GSK3β acetylation in CD8+ T cells.